DJ-1 inhibits TRAIL-induced apoptosis by blocking pro-caspase-8 recruitment to FADD

K Fu1, H Ren, Y Wang

  • 1Laboratory of Molecular Neuropathology, Department of Neurobiology, Key Laboratory of Brain Function and Disease and School of Life Sciences, University of Science & Technology of China, Chinese Academy of Sciences, Hefei, Anhui, PR China.

Oncogene
|July 26, 2011
PubMed

Insights

DJ-1 protein guards cells against programmed cell death (apoptosis) induced by TRAIL. It achieves this by preventing the assembly of the death-inducing signaling complex (DISC), a key step in apoptosis.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • DJ-1 is implicated in human tumorigenesis and Parkinson's disease (PD).
  • DJ-1 is known to protect cells from TRAIL-induced apoptosis, but the underlying mechanism remains unclear.
  • TRAIL-induced apoptosis is a critical cellular process regulated by death-inducing signaling complexes (DISCs).

Purpose of the Study:

  • To elucidate the mechanism by which DJ-1 inhibits TRAIL-induced apoptosis.
  • To investigate the interaction between DJ-1 and components of the apoptosis signaling pathway.

Main Methods:

  • Investigated the role of DJ-1 in TRAIL-induced apoptosis.
  • Utilized wild-type and PD-associated mutant L166P DJ-1.
  • Examined the binding of DJ-1 to Fas-associated protein death domain (FADD).
  • Assessed the formation of the death-inducing signaling complex (DISC) and pro-caspase-8 activation.

Main Results:

  • Wild-type DJ-1, but not the L166P mutant, binds to FADD.
  • DJ-1 binding to FADD inhibits the formation of the DISC.
  • DJ-1 competes with pro-caspase-8 for FADD binding, thereby preventing pro-caspase-8 activation.

Conclusions:

  • DJ-1 protects against TRAIL-induced apoptosis by directly inhibiting DISC formation.
  • DJ-1's interaction with FADD is crucial for its anti-apoptotic function.
  • Dysregulation of DJ-1's interaction with FADD may contribute to diseases like PD and cancer.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...